BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1322812)

  • 21. Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.
    Shepherd FA; Ginsberg RJ; Haddad R; Feld R; Sagman U; Evans WK; DeBoer G; Maki E
    J Clin Oncol; 1993 Aug; 11(8):1592-7. PubMed ID: 8393098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of the bone scan and bone marrow biopsy staging small cell lung cancer.
    Levitan N; Byrne RE; Bromer RH; Faling LJ; Caslowitz P; Pattern DH; Hong WK
    Cancer; 1985 Aug; 56(3):652-4. PubMed ID: 2988751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current perspectives in the management of small cell lung cancer].
    Fujita J; Saijo N
    Gan No Rinsho; 1985 Jan; 31(1):1-19. PubMed ID: 2984443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
    Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
    J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small cell carcinoma of the lung exclusively localized within the left descending pulmonary artery.
    Kamigaki M; Yamazaki K; Tsujino I; Suga M; Sakaue S; Dosaka-Akita H; Nishimura M
    Chest; 2005 Jun; 127(6):2273-6. PubMed ID: 15947349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
    Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
    J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The benefit of chemotherapy in elderly patients with small cell lung cancer.
    Caprario LC; Strauss GM
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):645-7. PubMed ID: 24655123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
    Osterlind K; Andersen PK
    Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of small cell lung cancer.
    Harvey VJ; Kolbe J
    N Z Med J; 1986 Feb; 99(796):104-6. PubMed ID: 3005933
    [No Abstract]   [Full Text] [Related]  

  • 30. Multimodality treatment of small-cell bronchial carcinomas: problems of evaluation and staging. The Cooperative ISC Lung Cancer Study Group.
    Karrer K; Denck H
    Chemioterapia; 1987 Jun; 6(2 Suppl):698-700. PubMed ID: 2855620
    [No Abstract]   [Full Text] [Related]  

  • 31. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
    Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
    J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NCCN: Small cell lung cancer.
    Johnson BE;
    Cancer Control; 2001; 8(6 Suppl 2):32-43. PubMed ID: 11760556
    [No Abstract]   [Full Text] [Related]  

  • 34. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994.
    Lebitasy MP; Hédelin G; Purohit A; Moreau L; Klinzig F; Quoix E
    Br J Cancer; 2001 Sep; 85(6):808-15. PubMed ID: 11556829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The therapeutic procedure at the 1st stage of the combined therapy of patients with small-cell ling cancer].
    Boĭko AV; Trakhtenberg AKh; Kiseleva ES; Frank GA; Zvekotkina LS
    Vopr Onkol; 1989; 35(2):167-72. PubMed ID: 2538960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Small-cell lung cancer].
    Pérez-Gracia JL; López-Picazo JM; Martín-Algarra S; Viteri S; García-Foncillas J; Gúrpide A
    Rev Med Univ Navarra; 2007; 51(2):7-13. PubMed ID: 17886708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and evolving treatment options for limited stage small cell lung cancer.
    Lee CB; Morris DE; Fried DB; Socinski MA
    Curr Opin Oncol; 2006 Mar; 18(2):162-72. PubMed ID: 16462186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auditing a new lung cancer service.
    Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
    Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
    Albain KS; Crowley JJ; LeBlanc M; Livingston RB
    J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.